Rajeev H Muni1,2,3, Carolina L M Francisconi4, Tina Felfeli1, Michael Y K Mak5, Alan R Berger1,2, David T Wong1,2, Filiberto Altomare1,2, Louis R Giavedoni1,2, Radha P Kohly1,3,6, Peter J Kertes1,3,6, Natalia Figueiredo2, Fei Zuo7, Kevin E Thorpe7,8, Roxane J Hillier9,10. 1. Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada. 2. St Michael's Hospital, Department of Ophthalmology, Unity Health Toronto, Toronto, Ontario, Canada. 3. Kensington Vision and Research Centre, University of Toronto, Toronto, Ontario, Canada. 4. Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada. 5. Division of Ophthalmology, Department of Surgery, University of Calgary, Calgary, Alberta, Canada. 6. The John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 7. Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada. 8. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 9. Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, England. 10. Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, England.
Abstract
Importance: Although rhegmatogenous retinal detachment (RRD) repair techniques have high anatomical reattachment rates, there may be differences in various aspects of postoperative vision-related quality of life (VRQoL). Objective: To explore the differences in various aspects of VRQoL between pneumatic retinopexy (PnR) and pars plana vitrectomy (PPV) following RRD repair. Design, Setting, and Participants: Post hoc exploratory analysis of the the Pneumatic Retinopexy vs Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes randomized clinical trial conducted between August 2012 and May 2017 at St Michael's Hospital, Toronto, Ontario, Canada. Patients with RRD with a single break or multiple breaks within 1 clock hour of detached retina in the superior 8 clock hours of the retina with any number, location, and size of retinal breaks or lattice degeneration in attached retina. Main Outcomes and Measures: Differences in the 25-Item National Eye Institute Visual FunctionQuestionnaire 12 subscale scores between the PnR and PPV groups at 6 months following RRD repair. Results: A total of 160 patients were included in this analysis, with 81 patients (92%) and 79 patients (90%) in the PnR and PPV groups, respectively. The PnR group consisted of 32% women with a mean (SD) age of 60.9 (9.3) years, while the PPV group consisted of 38% women with a mean (SD) age of 60.3 (7.6) years. For the 152 patients with 6-month follow-up (75 patients in PnR [85%] and 77 patients in PPV [88%]), there was evidence for an association of PnR with superior vision-related functioning compared with PPV for several subscales. There were no differences between groups at 1 year. After adjusting for age, sex, baseline macular status, visual acuity in the nonstudy eye, and lens status, patients who underwent PnR had higher scores for distance activities (mean [SD] PnR, 88.7 [13.4]; PPV, 82.8 [17.1]; adjusted difference, 6.5; 95% CI, 1.6-11.4; P = .01), mental health (mean [SD] PnR, 84.3 [17.4]; PPV, 78.7 [21.1]; adjusted difference, 6.7; 95% CI, 0.4-13; P = .04), dependency (mean [SD] PnR, 96.1 [10.1]; PPV, 91.1 [18.6]; adjusted difference, 5.7; 95% CI, 0.6-10.8; P = .03), and peripheral vision (mean [SD] PnR, 91.6 [16.2]; PPV, 81.2 [24.4]; adjusted difference, 10.8; 95% CI, 4.3-17.4; P = .001) at 6 months. Conclusions and Relevance: These findings demonstrate that patients undergoing PnR for RRD report highermental health scores and superior vision-related functioning scores in several subscales of the 25-Item National Eye Institute Visual Function Questionnaire during the first 6 months postoperatively compared with PPV. Trial Registration: ClinicalTrials.gov Identifier: NCT01639209.
RCT Entities:
Importance: Although rhegmatogenous retinal detachment (RRD) repair techniques have high anatomical reattachment rates, there may be differences in various aspects of postoperative vision-related quality of life (VRQoL). Objective: To explore the differences in various aspects of VRQoL between pneumatic retinopexy (PnR) and pars plana vitrectomy (PPV) following RRD repair. Design, Setting, and Participants: Post hoc exploratory analysis of the the Pneumatic Retinopexy vs Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes randomized clinical trial conducted between August 2012 and May 2017 at St Michael's Hospital, Toronto, Ontario, Canada. Patients with RRD with a single break or multiple breaks within 1 clock hour of detached retina in the superior 8 clock hours of the retina with any number, location, and size of retinal breaks or lattice degeneration in attached retina. Main Outcomes and Measures: Differences in the 25-Item National Eye Institute Visual Function Questionnaire 12 subscale scores between the PnR and PPV groups at 6 months following RRD repair. Results: A total of 160 patients were included in this analysis, with 81 patients (92%) and 79 patients (90%) in the PnR and PPV groups, respectively. The PnR group consisted of 32% women with a mean (SD) age of 60.9 (9.3) years, while the PPV group consisted of 38% women with a mean (SD) age of 60.3 (7.6) years. For the 152 patients with 6-month follow-up (75 patients in PnR [85%] and 77 patients in PPV [88%]), there was evidence for an association of PnR with superior vision-related functioning compared with PPV for several subscales. There were no differences between groups at 1 year. After adjusting for age, sex, baseline macular status, visual acuity in the nonstudy eye, and lens status, patients who underwent PnR had higher scores for distance activities (mean [SD] PnR, 88.7 [13.4]; PPV, 82.8 [17.1]; adjusted difference, 6.5; 95% CI, 1.6-11.4; P = .01), mental health (mean [SD] PnR, 84.3 [17.4]; PPV, 78.7 [21.1]; adjusted difference, 6.7; 95% CI, 0.4-13; P = .04), dependency (mean [SD] PnR, 96.1 [10.1]; PPV, 91.1 [18.6]; adjusted difference, 5.7; 95% CI, 0.6-10.8; P = .03), and peripheral vision (mean [SD] PnR, 91.6 [16.2]; PPV, 81.2 [24.4]; adjusted difference, 10.8; 95% CI, 4.3-17.4; P = .001) at 6 months. Conclusions and Relevance: These findings demonstrate that patients undergoing PnR for RRD report higher mental health scores and superior vision-related functioning scores in several subscales of the 25-Item National Eye Institute Visual Function Questionnaire during the first 6 months postoperatively compared with PPV. Trial Registration: ClinicalTrials.gov Identifier: NCT01639209.
Authors: P E Tornambe; G F Hilton; D A Brinton; T P Flood; S Green; W S Grizzard; M E Hammer; S R Leff; L Masciulli; C M Morgan Journal: Ophthalmology Date: 1991-07 Impact factor: 12.079
Authors: Roxane J Hillier; Tina Felfeli; Alan R Berger; David T Wong; Filiberto Altomare; David Dai; Louis R Giavedoni; Peter J Kertes; Radha P Kohly; Rajeev H Muni Journal: Ophthalmology Date: 2018-11-22 Impact factor: 12.079
Authors: Danny Mitry; James Chalmers; Kirsty Anderson; Linda Williams; Brian W Fleck; Alan Wright; Harry Campbell Journal: Br J Ophthalmol Date: 2010-07-07 Impact factor: 4.638
Authors: Ivan J Suñer; Gregg T Kokame; Elaine Yu; James Ward; Chantal Dolan; Neil M Bressler Journal: Invest Ophthalmol Vis Sci Date: 2009-02-28 Impact factor: 4.799
Authors: Kien Gia To; Lynn B Meuleners; Michelle L Fraser; Dung Van Do; Dat Van Duong; Van-Anh Ngoc Huynh; Quyen Gia To; Tien Duy Phi; Hoang Huy Tran; Nguyen Do Nguyen Journal: Health Qual Life Outcomes Date: 2014-02-06 Impact factor: 3.186
Authors: Rajeev H Muni; Tina Felfeli; Srinivas R Sadda; Verena R Juncal; Carolina L M Francisconi; Muneeswar Gupta Nittala; Sophiana Lindenberg; Frederic Gunnemann; Alan R Berger; David T Wong; Filiberto Altomare; Louis R Giavedoni; Radha P Kohly; Peter J Kertes; David Sarraf; Roxane J Hillier Journal: JAMA Ophthalmol Date: 2021-06-01 Impact factor: 7.389
Authors: Nicolas A Yannuzzi; Charles Li; Danielle Fujino; Scott P Kelly; Flora Lum; Harry W Flynn; D Wilkin Parke Journal: JAMA Ophthalmol Date: 2021-06-17 Impact factor: 8.253